...











...

The National Cancer Institute, NIH, DHHS, is paving the way for new programs and discoveries at NCI-Frederick.  The HIV Drug Resistance Program (DRP) is a world-class center for retrovirology research in a highly collaborative environment dedicated purely to research and supported by a wide spectrum of state-of-the-art core facilities.  The emphasis of the DRP is on basic and translational research related to genetic diversity and drug resistance.

Currently, the DRP is recruiting for the following positions:


Selection of these positions will be based on merit, without discrimination for nonmerit reasons such as race, color, religion, gender, national origin, politics, marital status, physical or mental disability, age, sexual orientation, or membership or nonmembership in an employee organization.  These positions are subject to a background investigation.

Note for Foreign Scientists:  Applicants should be aware that the recruitment process is lengthy.  Anyone currently holding a J1 visa and transferring from an academic institution would be limited to three years from entrance into the United States.  For additional information, please visit the web site of the Fogarty International Center.

The National Cancer Institute, NIH, DHHS, is an Equal Employment Opportunity and Affirmative Action employer that values and fosters diversity throughout the entire organization.

...



HIV DRP Home
Mission | HIV DRP Symposium | News & Events | Research Team | Clinical Trials | Recruitment | Resources
Related Sites | Staff Directory | NCI Home | NCI-Frederick | Site Map | Disclaimers | Contact Us